DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Reset all filters
01 3Dr. Reddy's Laboratories
02 6Strides Pharma Science
03 1AVIV PHARMA
04 1Acella Pharmaceuticals
05 13Actavis Inc
06 1Aeon Formulations Private Limited
07 4Ajanta Pharma Limited
08 11Alembic Pharmaceuticals Limited
09 5Amneal Pharmaceuticals
10 1Anwita Drugs
11 4Apotex Inc
12 1Aspiro Pharma
13 1Aurobindo Pharma Limited
14 7Avet Pharmaceuticals
15 2Bausch & Lomb Incorporated
16 2Bionpharma
17 3Cantabria Labs
18 2Changzhou Pharmaceutical Factory
19 9Chartwell Pharmaceuticals llc
20 1DenMat Dental
21 5Epic Pharma. LLC.
22 2Fresenius Kabi USA
23 1GALDERMA LABS LP
24 1GLAND PHARMA LIMITED
25 1Galderma
26 2HALSEY
27 3HEATHER
28 8Hikma Pharmaceuticals
29 1Holden Medical Laboratories Pvt. Ltd
30 3Hospira, Inc.
31 2Impax Laboratories
32 3Interpharm
33 2JAMP PHARMA
34 1Kindos Pharmaceuticals
35 1Kulzer Gmbh
36 1LABORATOIRE RIVA INC.
37 1LABORATORIOS NORMON SA
38 1LARKEN LABS
39 1Laboratorios Llorens Sa
40 1Llorens Laboratories Sl
41 11Lupin Ltd
42 1MANTRA PHARMA INC
43 2MS Pharma
44 10Mayne Pharma
45 3Mutual Pharmaceutical Company, Inc.
46 1Neopharma
47 2Nesher Pharmaceuticals USA LLC
48 1Novel Laboratories, Inc.
49 1Oryza Pharmaceuticals
50 1PH HEALTH
51 1PRO DOC LIMITEE
52 2PVT FORM
53 1Pantex Holland
54 2Par Pharmaceutical
55 4Pelcoat Formulations
56 5Pfizer Inc
57 1Pharmaris
58 3Pharmascience Inc.
59 1Pliva Hrvatska
60 1Praxgen
61 1Precision Dose
62 3Prinston
63 2Qilu Animal Health Products
64 2Quad Pharma
65 1RACHELLE
66 7Rising Pharmaceuticals Inc
67 2SANIS HEALTH INC
68 3SUPERPHARM
69 2Shijiazhuang Fengqiang Animal Pharmaceutical Co., Ltd
70 2Slate Run Pharmaceuticals
71 6Sun Pharmaceutical Industries Limited
72 1Teofarma
73 5Teva Pharmaceutical Industries
74 2Torrent Pharmaceuticals Limited
75 2Unichem Laboratories Limited
76 2V-Ensure
77 2Viatris
78 1Virjo Healthcare
79 4Warner Chilcott Company, LLC
80 2West-ward Pharmaceutical Corp
81 2Zhejiang Yongtai Technology
82 3Zydus Lifesciences
83 5Zydus Pharmaceuticals
Reset all filters
01 9CAPSULE
02 1CAPSULE, COATED PELLETS;ORAL
03 5CAPSULE, DELAYED RELEASE;ORAL
04 53CAPSULE;ORAL
05 7Capsule
06 1Capsule IP
07 1Coated Tablet
08 4Enteric Coated Pellets
09 5Hard Capsule
10 25INJECTABLE;INJECTION
11 1Inection
12 1Injectable And Infusion Solution
13 2Injectable; Injection
14 1Injection
15 1Oral Solution/Suspension
16 1Oral Suspension
17 1PELLET
18 1Periodontal Gel
19 2Powder
20 1SYSTEM, EXTENDED RELEASE;PERIODONTAL
21 9TABLET
22 42TABLET, DELAYED RELEASE;ORAL
23 57TABLET;ORAL
24 2Tablet
25 1WSP / Premix
26 1Water Soluble Powder
Reset all filters
01 8Authorized
02 3Cancelled
03 102DISCN
04 6Generic
05 15Prescription
06 82RX
07 19Blank
Reset all filters
01 2ACTICLATE
02 1ACTICLATE CAP
03 1APO-DOXY CAP 100MG
04 1APO-DOXY TABS 100MG
05 1ATRIDOX
06 9DORYX
07 2DORYX MPC
08 1DOXIEONnn
09 1DOXY 100
10 1DOXY 200
11 3DOXY-LEMMON
12 1DOXYCHEL HYCLATE
13 1DOXYCIN TAB 100MG
14 7DOXYCYCLINE
15 1DOXYCYCLINE CAPSULES
16 150DOXYCYCLINE HYCLATE
17 1DOXYCYCLINE TABLETS
18 1DOXYTAB
19 1Dosil
20 1Dosil Enzymatic Capsules
21 1Doxiciclina Normon
22 1Doxiten Bio
23 3Doxycycline Hyclate
24 1Doxyline-100
25 1Doxyline-200
26 2Doxy®
27 1Gendox 10/5
28 1JAMP DOXYCYCLINE
29 1JAMP DOXYCYCLINE CAPSULES
30 1LYMEPAK
31 1Ligosan
32 1M-DOXYCYCLINE
33 1Neocycline
34 2PERIOSTAT
35 3PMS-DOXYCYCLINE
36 1PRZ-DOXYCYCLINE
37 3Proderma
38 2TEVA-DOXYCYCLINE
39 1VIBRA-TABS
40 4VIBRAMYCIN
41 2Vibracina
42 1Vibravenosa
43 13Blank
Reset all filters
01 15Canada
02 4China
03 15India
04 2Jordan
05 1Netherlands
06 11Spain
07 1U.A.E
08 186USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXYCYCLINE HYCLATE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 75MG BASE
Packaging :
Approval Date : 2017-06-14
Application Number : 208765
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXYCYCLINE HYCLATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 50MG BASE
Packaging :
Approval Date : 1982-03-29
Application Number : 62337
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXYCYCLINE HYCLATE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 150MG BASE
Packaging :
Approval Date : 2017-06-14
Application Number : 208765
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXYCYCLINE HYCLATE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 100MG BASE/VIAL
Packaging :
Approval Date : 2025-07-01
Application Number : 218753
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXYCYCLINE HYCLATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 1982-03-29
Application Number : 62337
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DOXYCYCLINE HYCLATE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 1986-04-07
Application Number : 62538
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info :
Registration Country : India
Brand Name : Doxycycline Hyclate
Dosage Form : Tablet
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name : Doxycycline Hyclate
Dosage Form : Capsule
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name : Doxycycline Hyclate
Dosage Form : Capsule
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ATRIDOX
Dosage Form : SYSTEM, EXTENDED RELEASE;PERIODONTAL
Dosage Strength : 50MG
Packaging :
Approval Date : 1998-09-03
Application Number : 50751
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : PERIOSTAT
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1998-09-30
Application Number : 50744
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : PERIOSTAT
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2001-02-02
Application Number : 50783
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DORYX
Dosage Form : CAPSULE, DELAYED RELEASE;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 1985-07-22
Application Number : 50582
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DORYX
Dosage Form : CAPSULE, DELAYED RELEASE;ORAL
Dosage Strength : EQ 75MG BASE
Packaging :
Approval Date : 2001-08-13
Application Number : 50582
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DORYX
Dosage Form : TABLET, DELAYED RELEASE;ORAL
Dosage Strength : EQ 75MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2005-05-06
Application Number : 50795
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : VIBRAMYCIN
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 50MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1982-01-01
Application Number : 50007
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : VIBRAMYCIN
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 1982-01-01
Application Number : 50007
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : VIBRAMYCIN
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 200MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1982-01-01
Application Number : 50442
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : VIBRAMYCIN
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 100MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1982-01-01
Application Number : 50442
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : VIBRA-TABS
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1982-01-01
Application Number : 50533
Regulatory Info : DISCN
Registration Country : USA